Our mission is to develop new therapies to reduce pain and its impact on quality of life.
Over 100 million people in the U.S. alone suffer from chronic pain, but the treatments available to these patients are few and their use is limited by severe side effects of these medications. Unfortunately for these individuals, little progress has been made in the development of new types of medications to treat chronic pain.
In our lab, we utilize a combination of behavioral studies, patch clamp electrophysiology, optogenetics, in vivo imaging, molecular and genetic approaches to understand the signaling pathways involved in nervous system plasticity that underlies pain sensitization. Our mission is to identify novel approaches to reverse this maladaptive plasticity to provide new therapeutic strategies to reduce pain and its impact on patient quality of life.
Work in the lab also includes clinical science aimed at translating findings from the lab into new or improved therapies for patients with pain. These studies include comparative studies of human physiology to preclinical models, as well as healthy human volunteer studies aimed at establishing proof of concept for novel analgesic therapies based on findings from the laboratory.
Research
Studies in the Gereau Lab are aimed at determining the circuit, cellular, and molecular mechanisms involved in the development of chronic pain conditions.
Our Team
Our team is a mosaic of talent, passion, and expertise — each contributing a unique perspective to our collective mission. Meet the faces behind our research!
News
Society of General Physiologists honors Dr. Del Rosario with Excelsior Award
Understanding, treating pain, reducing opioid use, aim of $11.7 million grant (Links to an external site)
Saving a Life When No One Is Around (Links to an external site)
